GradedCalls Analysts
Loading the ledger…
GradedCalls Analysts
Loading the ledger…
NYSE · Healthcare
AbbVie · Pharmaceuticals. Historical grades below use the calls in this ledger. The list is each analyst’s latest recommendation. The bar under it is the direction for grading, not a live street tally.
Direction for grading, from the latest active call of each analyst. Strong Buy, Buy, Overweight, and Outperform count as Buy. Hold, Neutral, and Equal-Weight count as Hold. Underperform, Underweight, and Sell count as Sell. The recommendation on the call — Target raise, Upgrade to Buy, Reiterate Overweight — is a separate label.
Overall factor · 30D
60.6/100Average of active call grades
GC score7/10GC 1→GC 10
GC 5–7. From 40 up to 70 is PROVISIONAL on the GC Scale.
The overall factor is the average of the 0–100 grades on active calls at this horizon. A call superseded by a later note on the same ticker within 90 days stays visible and does not enter this average, the GC score, or the hit rate. How this is computed
| Analyst | Firm | N | Hit | Overall factor/100 · GC 1–10 |
|---|---|---|---|---|
| Navann Ty | BNP Paribas | 1 | 100% | 100/10010/10 |
| Alexandria Hammond | Wolfe | 1 | 100% | 70/1008/10 |
| Gary Nachman | Canaccord | 1 | 100% | 70 |
History only. A later call on the same ticker within 90 days replaced these. The notes stay. They do not enter the overall factor.
| Date | Analyst | Recommendation | Directionfor grading | Target | Then | After | Return | Grade |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 Nullified Nullified — superseded by later call on Oct 7, 2026 (within 90 days). Later call | Terence FlynnMorgan Stanley | Target raise Desk rating stays Overweight | Buy | $260.12 | +6.8% | Hit Not scored |
Active graded
8
In this factor
Superseded
1
Visible, not scored
Hit rate
63%
Active calls only
If followed
+3.8%
Active directional calls
Active calls on ABBV were a full hit 63% of the time. Hit rate is not the rank.
| Mohit Bansal | Wells Fargo | 1 | 100% | 70/1008/10 |
| Rajesh Kumar | HSBC | 1 | 100% | 70/1008/10 |
| Gavin Clark-Gartner | Evercore | 1 | 0% | 63.8/1007/10 |
| Steve Scala | TD Cowen | 1 | 0% | 40.8/1005/10 |
| David Amsellem | Piper | 1 | 0% | 0/100—/10 EXIT LIQUIDITY |